95 related articles for article (PubMed ID: 31845843)
21. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions.
Aslam A; Do RKG; Kambadakone A; Spieler B; Miller FH; Gabr AM; Charalel RA; Kim CY; Madoff DC; Mendiratta-Lala M
World J Hepatol; 2020 Oct; 12(10):738-753. PubMed ID: 33200013
[TBL] [Abstract][Full Text] [Related]
23. Moving Away from Uncertainty: A Potential Role for Ancillary Features in LI-RADS Treatment Response.
Do RK; Mendiratta-Lala M
Radiology; 2020 Sep; 296(3):562-563. PubMed ID: 32697166
[No Abstract] [Full Text] [Related]
24. Imaging diagnosis of hepatocellular carcinoma: LI-RADS.
Cunha GM; Sirlin CB; Fowler KJ
Chin Clin Oncol; 2021 Feb; 10(1):3. PubMed ID: 32527115
[TBL] [Abstract][Full Text] [Related]
25. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
[TBL] [Abstract][Full Text] [Related]
26. Liver Stiffness Measured with Two-dimensional Shear-Wave Elastography Is Predictive of Liver-related Events in Patients with Chronic Liver Disease Due to Hepatis B Viral Infection.
Wu M; Wu L; Jin J; Wang J; Li S; Zeng J; Guo H; Zheng J; Chen S; Zheng R
Radiology; 2020 May; 295(2):353-360. PubMed ID: 32125254
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
Han A; Byra M; Heba E; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
Radiology; 2020 May; 295(2):342-350. PubMed ID: 32096706
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
[TBL] [Abstract][Full Text] [Related]
29. Use of Gadoxetic Acid-enhanced Liver MRI and Mortality in More than 30 000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis.
Kang TW; Kong SY; Kang D; Kang MW; Kim YK; Kim SH; Sinn DH; Kim YA; Choi KS; Lee ES; Woo SM; Back JH; Guallar E; Cho J
Radiology; 2020 Apr; 295(1):114-124. PubMed ID: 32013789
[TBL] [Abstract][Full Text] [Related]
30. Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy.
Abdel Razek AAK; El-Serougy LG; Saleh GA; Shabana W; Abd El-Wahab R
Diagn Interv Imaging; 2020 Sep; 101(9):547-553. PubMed ID: 32253141
[TBL] [Abstract][Full Text] [Related]
31. Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category.
Park HJ; Kim YK; Cha DI; Ko SE; Kim S; Lee ES; Ahn S
Clin Radiol; 2020 Jun; 75(6):478.e13-478.e23. PubMed ID: 32033745
[TBL] [Abstract][Full Text] [Related]
32. Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization.
Ormiston WEL; Yarmohammadi H; Lobaugh S; Schilsky J; Katz SS; LaGratta M; Velayati S; Zheng J; Capanu M; Do RKG
Abdom Radiol (NY); 2021 Aug; 46(8):3738-3747. PubMed ID: 32968863
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
[TBL] [Abstract][Full Text] [Related]
34. LI-RADS Version 2018 Treatment Response Algorithm: Diagnostic Performance after Transarterial Radioembolization for Hepatocellular Carcinoma.
Yoon J; Lee S; Shin J; Kim SS; Kim GM; Won JY
Korean J Radiol; 2021 Aug; 22(8):1279-1288. PubMed ID: 33987991
[TBL] [Abstract][Full Text] [Related]
35. Liver imaging reporting and data system (LI-RADS) v2018: Reliability and agreement for assessing hepatocellular carcinoma locoregional treatment response.
Abdelrahman AS; Ekladious MEY; Badran EM; Madkour SS
Diagn Interv Imaging; 2022 Nov; 103(11):524-534. PubMed ID: 35787988
[TBL] [Abstract][Full Text] [Related]
36. Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma.
Kim YY; Kim MJ; Yoon JK; Shin J; Roh YH
AJR Am J Roentgenol; 2022 Mar; 218(3):484-493. PubMed ID: 34585608
[No Abstract] [Full Text] [Related]
37. Deep learning-based arterial subtraction images improve the detection of LR-TR algorithm for viable HCC on extracellular agents-enhanced MRI.
Wang Y; Yang D; Xu L; Yang S; Wang W; Zheng C; Zhang X; Wu B; Yin H; Yang Z; Xu H
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38642094
[TBL] [Abstract][Full Text] [Related]
38. LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features.
Wang D; Zhang Y; Lyu R; Jia K; Xu PJ
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38605217
[TBL] [Abstract][Full Text] [Related]
39. Evidence Supporting Diagnostic Value of Liver Imaging Reporting and Data System for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Suhail Najm Alareer H; Arian A; Fotouhi M; Taher HJ; Dinar Abdullah A
J Biomed Phys Eng; 2024 Feb; 14(1):5-20. PubMed ID: 38357604
[TBL] [Abstract][Full Text] [Related]
40. Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives.
Herrero A; Toubert C; Bedoya JU; Assenat E; Guiu B; Panaro F; Bardol T; Cassese G
Hepatobiliary Surg Nutr; 2024 Feb; 13(1):71-88. PubMed ID: 38322198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]